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Sir2 and insulin/IGF-1 are the major pathways that impinge upon aging in lower organisms. In Caenorhabditis elegans a
possible genetic link between Sir2 and the insulin/IGF-1 pathway has been reported. Here we investigate such a link in
mammals. We show that Sirt1 positively regulates insulin secretion in pancreatic b cells. Sirt1 represses the uncoupling
protein (UCP) gene UCP2 by binding directly to the UCP2 promoter. In b cell lines in which Sirt1 is reduced by SiRNA,
UCP2 levels are elevated and insulin secretion is blunted. The up-regulation of UCP2 is associated with a failure of cells
to increase ATP levels after glucose stimulation. Knockdown of UCP2 restores the ability to secrete insulin in cells with
reduced Sirt1, showing that UCP2 causes the defect in glucose-stimulated insulin secretion. Food deprivation induces
UCP2 in mouse pancreas, which may occur via a reduction in NAD (a derivative of niacin) levels in the pancreas and
down-regulation of Sirt1. Sirt1 knockout mice display constitutively high UCP2 expression. Our findings show that Sirt1
regulates UCP2 in b cells to affect insulin secretion.
Citation: Bordone L, Motta MC, Picard F, Robinson A, Jhala US, et al. (2006) Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic b cells. PLoS Biol 4(2): e31.
Introduction
Glucose homeostasis is maintained, in part, by pancreatic b
cells, which secrete insulin in a highly regulated sequence of
dependent events [1]. b cells metabolize glucose, resulting in
an increase in the ATP/ADP ratio, the closing of the ATP-
dependent K
þ channel, the activation of the voltage-gated
Ca
þ channel and Ca
þ inﬂux, and the fusion of secretory
vesicles to the plasma membrane to release insulin. Insulin is
part of an organismal physiological axis in which it stimulates
glucose uptake in metabolic tissues, such as muscle, and stores
energy in the form of fat in white adipose tissue (WAT).
Short-term food limitation (i.e., overnight [O/N] fasting) will
therefore elicit the mobilization of glycogen stores and then
fat from WAT for metabolism, and the lower level of blood
glucose during fasting will result in low levels of insulin
production by b cells.
Long-term calorie restriction (CR) has been known for 70
years to extend the life span of mammals dramatically [2], and
it can also work in a variety of organisms, including yeast,
ﬂies, and rodents [3–5], although the mechanism of this effect
has remained obscure. In mammals a characteristic set of
physiological changes takes place during long-term CR, which
overlaps the rapid physiological adaptations to short-term
food limitation. One such change is the use of dietary fat or
fat mobilized from WAT for energy [4]. Another is a large
reduction in blood insulin levels accompanied by an increase
in insulin sensitivity, i.e., the ability of insulin to promote
glucose utilization [4]. In addition, gluconeogenesis is
activated in the liver. These changes keep glucose available
for the brain, and are closely associated with the longevity
elicited by CR. The paucity of fat in WAT appears to be
sufﬁcient per se to promote a degree of longevity, since mice
engineered for leanness—for example, a WAT-speciﬁc knock-
out (KO) of the insulin receptor—live longer [6,7].
Findings in model organisms suggest a mechanism for the
longevity engendered by CR that implicates the silent mating
type information regulation 2 gene (Sir2). This gene regulates
the life span in yeast [8] and Caenorhabditis elegans [9] as a
longevity determinant. In yeast, CR works by up-regulating
the activity of Sir2 [10,11], a NAD-dependent deacetylase [12–
14] (NAD is a derivative of niacin), by increasing respiration,
and by increasing the NAD/NADH ratio [15] (NADH is the
reduced form of NAD). CR is also reported to activate the
NAD salvage pathway, which would deplete a Sir2 inhibitor,
nicotinamide [3,10]. The Drosophila melanogaster Sir2 gene was
also shown to mediate life extension in response to dietary
restriction [16,17].
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PLoS BIOLOGYSince Sir2 appears to mediate the effects of CR on life span
in simple model organisms, it seemed possible that Sir2
proteins also regulate the effects of food limitation and CR in
mammals. The homolog of the yeast silencing information
regulator2 (Sirt1) has also been implicated in several aspects
of food limitation and CR in mammals. In WAT, Sirt1
represses the key regulatory protein peroxisome proliferator-
activated receptor gamma (PPARc), resulting in fat mobi-
lization in response to food limitation [18]. In addition, Sirt1
regulates the FOXO (forkhead Box O) set of forkhead
transcription factors [19,20], providing another link to
metabolism and diet. Also, gluconeogenesis in the liver is
regulated by Sirt1 [19], which works in concert with the
transcriptional co-activator, peroxisome proliferator-acti-
vated receptor coactivator, PGC-1a [21]. Finally, Sirt1 may
play a role in the observed stress resistance of CR animals,
since it down-regulates several pro-apoptotic factors, such as
p53, FOXO, and Bax [19,20,22–25].
In addition to the classical paradigm for insulin regulation
by glucose outlined above, reports suggest a role of an
uncoupling protein (UCP) in insulin secretion. UCPs belong
to a family of mitochondrial inner membrane proteins. They
function to uncouple oxygen consumption during respiration
from the production of ATP by allowing proton leakage down
an electrochemical gradient from the cytoplasm to the
mitochondria [26–29]. Several mammalian UCP homologues
have been identiﬁed and characterized [28]. UCP2 has been
shown to promote proton leakage across the mitochondrial
membrane [30–33], and has been proposed to play a role in
lipid metabolism, insulin resistance, glucose utilization,
regulation of reactive oxygen species, and macrophage-
mediated immunity [28,34,35]. A role for UCP2 in insulin
secretion has been demonstrated, since UCP2 KO mice show
higher ATP levels in islets and increased insulin secretion
upon glucose stimulation [36]. Conversely, UCP2 overexpres-
sion in cultured b cell lines reduces ATP levels and glucose-
stimulated insulin secretion [37,38].
In this study, we show that Sirt1 functions as a positive
regulator of insulin secretion in response to glucose by
directly repressing the UCP2 gene. Our ﬁndings suggest that
UCP2 is thus used in b cells to modulate the insulin response
pathway as a function of diet. The fact that Sirt1 is a positive
regulator of insulin may seem surprising, in light of the fact
that sir-2.1 in C. elegans appears to be a negative regulator of
the insulin-like signaling pathway [9]. We discuss how this
difference makes sense in light of the physiological adapta-
tions that take place in mammals in response to dietary
changes.
Results
Sirt1 Is Preferentially Expressed in Pancreatic b Cells
To determine whether Sirt1 could potentially play a role in
b cells, immunoﬂuorescence of whole murine pancreas with
anti-Sirt1 antibody was carried out, and 20 islets were
examined by ﬂuorescence microscopy. A representative islet
Figure 1. Sirt1 Is Localized in the Islets of Langerhans
The pancreas of wild-type mice was sectioned and stained as described.
(A) Nuclear staining using DAPI (top left). Immunofluorescence using Sirt1 antibody (top right); hematoxylin and eosin staining of the same section of
pancreas (bottom left); immunofluorescence control using a rabbit secondary antibody (bottom right).
(B) Pancreases of wild-type (WT), Sirt1þ/  heterozygotes (HET), or Sirt1 /  homozygous KO mice were stained with antibodies against insulin (blue),
glucagon (red), or somatostatin (green) (shown in left column). Representative islets of mice of all three genotypes are shown. Pancreases were also
silver-stained for morphometry (right column). Islets appear as dark figures and their area was determined by scanning, using Image-Pro 4.1 Plus
software.
(C) The areas are shown as percentage of area of the entire pancreas.
DOI: 10.1371/journal.pbio.0040031.g001
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Sirt1 Regulates Insulin Secretionis shown in Figure 1A (see lower left panel for hematoxylin-
eosin staining). All pancreatic sections examined showed
intense staining concentrated in islets using Sirt1 antibodies
(Figure 1A, top right) but not with secondary antibody alone
(Figure 1A, lower right), and a lower level of expression in the
surrounding exocrine cells. DAPI bright spots (Figure 1A, top
left) mark nuclei and their corresponding cells in the islets
and surrounding tissue. This enrichment of Sirt1 in the islets
and not exocrine cells is noteworthy, in light of the
ubiquitous expression of this sirtuin in most somatic and
germ tissues [39,40].
Sirt1 KO Mice Have Low Levels of Blood Insulin
Because Sirt1 is highly expressed in b cells, we investigated
whether this sirtuin plays a functional role in insulin
production. First, we determined whether Sirt1 KO mice
[39,40] showed any defects in the pancreatic b cells or the
islets. Pancreases from wild-type, Sirt1þ/  heterozygotes, or
Sirt1 / KO mice (4 5 each) were sectioned and stained with
antibodies against insulin (blue), glucagons (red), and
somatostatin (green). These stains mark islets for b cells, a
cells, and d cells, respectively. As shown in a typical section
(Figure 1B), no differences were observed in the staining
pattern of these three markers between wild-type and mutant
islets. We measured pancreatic islet areas using Image-Pro 4.1
Plus software, and expressed the islet areas as a percentage of
the total pancreatic area (Figure 1C). There were no
signiﬁcant differences in islet areas comparing wild-type,
heterozygous, and KO mice. The absolute islet size was also
not appreciably different in the mutant mice.
Next, we determined whether insulin production was
altered in Sirt1 KO mice. Blood insulin was measured in
males 2–4 mo old fed ad libitum or after 18 h of starvation
(Figure 2A). Sirt1 KO mice (black bars) had much lower blood
levels of insulin compared with littermate control animals
(open bars) when the samples were collected under ad libitum
conditions. This difference was also observed when the
animals were starved O/N, in which case insulin levels were
very low in both wild-type and KO mice. To assess more
precisely the ability of animals to produce insulin, mice were
given an injection of glucose after O/N starvation and insulin
was measured after 2, 10, and 20 min. Whereas insulin
induction was clearly evident in the wild-type mice at 10 min
(open bars), induction was not observed in Sirt1 KO animals
(black bars in Figure 2B, n¼4 or 5 for each measurement). A
similar trend was noted at 20 min.
To further investigate the defect in insulin production,
islets from four wild-type or four Sirt1 KO animals were
isolated and incubated in vitro with or without glucose for 1
h, and insulin secretion was determined. As shown in Figure
2C, the basal level of insulin secreted into the media from
islets of Sirt1 KO mice (black bars) was signiﬁcantly lower
than wild-type controls (open bars). Moreover, the islets
isolated from Sirt1 KO mice were not induced to secrete
insulin by glucose, while control islets were inducible, as
expected.
Levels of blood glucose were then determined and,
surprisingly, were lower in Sirt1 KO mice (Figure 2D).
Further, these mice appeared to be hypermetabolic, since
they ate more food per body weight than the wild-type
(unpublished data). These ﬁndings suggested that the KO
mice had a better ability to use the lower levels of insulin for
glucose uptake, i.e., were more insulin sensitive. To address
this possibility, we performed glucose tolerance tests in both
wild-type and KO mice by injecting glucose intraperitoneally
and measuring the kinetics of glucose clearance from the
blood. The KO mice cleared the glucose signiﬁcantly faster
than the wild-type (Figure 2E). This increased glucose
Figure 2. Sirt1 KO Mice Have a Lower Level of Insulin
(A) Plasma insulin levels in wild-type (open bars) or Sirt1 KO mice (black bars) ad libitum or after O/N starvation (n¼12 wild-type, 11 KO, *p , 0.03 in ad
libitum and O/N starvation mice, ANOVA).
(B) Plasma insulin levels in Sirt1 KO mice (black bar) compared with wild-type mice (open bars) 2, 10, or 20 min after injection with glucose (n¼4o r5 ,* p
, 0.05 compared with wild-type, ANOVA).
(C) Insulin secretion in islets isolated from wild-type (open bars) or Sirt1 KO mice (black bars) after induction by 20 mM glucose for 1 h (n¼4, *p , 0.005
in wild-type, ANOVA).
(D) Glucose levels in wild-type (open bars) and Sirt1 KO (black bars) mice (n ¼ 12 wild-type, 11 KO, *p , 0.03 ad libitum, ANOVA).
(E) Glucose tolerance tests in wild-type (black) and Sirt1 KO (green) mice (n ¼ 6, *p , 0.05 at 20, 40, 60, and 120 min).
DOI: 10.1371/journal.pbio.0040031.g002
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Sirt1 Regulates Insulin Secretiontolerance explains why the KO mice maintained lower levels
of blood glucose, even with reduced levels of insulin. The
surprising effect of knocking out Sirt1 on glucose tolerance
likely derives from tissues other than the pancreas and is
currently being investigated in greater detail. In summary, we
do not know whether the reduction in insulin in Sirt1 KO
mice is due to a b cell defect or is an indirect consequence of
increased glucose tolerance in these animals.
Sirt1 Drives Glucose-Induced Insulin Secretion in Cultured
Cells
To address whether Sirt1 played a positive role in insulin
production speciﬁcally in b-cells, the pancreatic b-cell lines,
INS-1 from rat, and MIN6 from mouse were employed. INS-1
cells were grown in culture, and nuclear expression of Sirt1
was evident by immunoﬂuorescence (Figure 3) and Western
blot (Figure 3C and 3E). INS-1 or MIN6 cells were treated
with 10 mM nicotinamide, an inhibitor of Sirt1 [41], for 48 h,
and the levels of insulin secreted into the media were
measured without and with induction by glucose (Figure 3B
and 3F, respectively). Whereas control cells showed robust
induction of insulin secretion by glucose, nicotinamide
treatment blocked this induction in both cell lines.
To test if the effects of nicotinamide were due speciﬁcally
to inhibition of Sirt1, levels of this sirtuin were lowered by
RNA interference. INS-1 and MIN6 cells were infected with a
retrovirus carrying a Sirt1-SiRNA construct [18] or a control
vector (pSUPER-SiRNA GFP), and stable cell lines were
created as puromycin-resistant infected pools. These cells
displayed Sirt1 protein levels that were knocked down
compared with drug-resistant control pools generated from
the vector (Figure 3C [INS-1] and 3E [MIN]). When these
stable Sirt1 knockdown cells (Figure 3D, 3F, and 3G) were
treated with glucose, induction of insulin secretion was
eliminated, whereas contemporaneous assays of vector con-
trol cells (open bars) showed normal induction (Figure 3D
and 3F).
We then tested if the defect in glucose-induced insulin
secretion was due to a different glucose uptake between
control and knockdown cells by measuring transport of
ﬂuorescence analog 2-NBDG. Glucose uptake [42,43] was not
reduced and was perhaps slightly elevated in this assay in the
knockdown cells (Figure 3G). Further, no decrease in the
glucose transporter Glut 2 was observed (unpublished data).
Finally, cell growth measurements revealed no difference in
the growth rate of INS-1 knockdown cells compared with
controls (Figure S1). These results show that knockdown of
Sirt1 suppresses glucose-stimulated insulin secretion in two
different b cell lines.
Figure 3. Sirt1 Is a Positive Regulator of Insulin Secretion in INS-1 and MIN6 Cells
(A) Immunofluorescence in INS-1 cells using Sirt1 antibody (green) and DAPI staining (blue). Nuclear localization of Sirt1 is evident.
(B) Induction of insulin secretion in INS-1 cells with 16.7 mM glucose (þ) compared with 4 mM glucose control ( ). The left side shows no nicotinamide
and the right side shows treatment with 10 mM nicotinamide for 48 h prior to induction (n ¼ 3 experiments done in triplicate, *p , 0.05 in the no
nicotinamide experiment, ANOVA).
(C) Western blot of Sirt1 in INS-1 cells with knockdown levels of the protein (SiRNA Sirt1) compared with control cells (pSUPER).
(D) INS-1 cells infected with the pSUPERretro SiRNA-GFP control (open bars) or pSUPER retro SiRNA-Sirt1 knockdown cells (black bars) were induced for
insulin secretion as in (B) (n ¼ 3 experiments done in triplicate, *p , 0.008 in the control experiment, ANOVA).
(E) Western blot of Sirt1 in MIN6 cells with knockdown levels of the protein (SiRNA Sirt1) compared with control cells (pSUPER).
(F) Glucose induction (20 mM versus 4 mM) of insulin secretion in MIN6 cells with the pSUPER control vector (open bars) or the SiRNA Sirt1 vector (black
bars) in the absence or presence of nicotinamide (n ¼ 3 experiments done in triplicate*p , 0.05 in the control without nicotinamide, ANOVA).
(G) Glucose uptake in INS-1 cells stably transfected with control or SiRNA Sirt1 vectors. 2-NBDG fluorescence was determined by flow cytometry 10 min
after addition and expressed as arbitrary units (n ¼ 2, *p , 0.0005 compared with no glucose).
DOI: 10.1371/journal.pbio.0040031.g003
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Sirt1 Regulates Insulin SecretionATP/ADP Ratio Is Lower in Sirt1 Knockdown Cells
We next sought to investigate the mechanism by which
Sirt1 regulates insulin secretion in b cells. First, we assayed
the RNA level of the INS1 gene, encoding insulin, by
Northern blot and found no difference in control versus
Sirt1 knockdown b cells (Figure 4A). Similarly, we found no
difference by Western blot in expression level of c/EBPb,a
transcription factor that regulates INS1 (Figure 4B). Because
the insulin receptor is part of an autocrine induction loop for
insulin [44], we also determined by Western blot the levels of
this receptor (a and b subunits) and observed no difference
between control and knockdown cells (Figure 4B). Next, we
investigated whether Sirt1 affected the levels of the K
þ
channel by Western blot, and again found no effect (Figure
4C). While this analysis suggests that Sirt1 does not function
by altering levels of these factors, it does not rule out the
possibility that Sirt1 regulates their activity.
Finally, because of the central role of ATP in insulin
secretion, we surmised that Sirt1 could play a role in the
energetics of glucose utilization in b cells. We thus measured
the ATP/ADP ratio in control and Sirt1 knockdown INS-1
cells after glucose induction. Control cells (Figure 4D, open
bars) responded to glucose by increasing the ratio of ATP to
ADP, as expected (Figure 4D). In contrast, in cells with the
knockdown levels of Sirt1 (Figure 4D, black bars), the ATP/
ADP ratio did not increase upon glucose stimulation. These
ﬁndings show that knocking down Sirt1 results in a defect in
ATP production in response to glucose. Basal ATP levels are
not signiﬁcantly altered in knockdown cells, consistent with
the fact that they grow as well as control cells.
UCP2 Levels Are Increased in Sirt1 KO Mice and
Knockdown Cells
One possibility for the failure of the Sirt1 knockdown cells
to make ATP is that respiration is more uncoupled than in
control cells, which would square well with the known link
Figure 4. UCP2 is Up-Regulated in Sirt1 Knockdown Cells and in Sirt1 KO Mice
(A) Northern blot for the insulin gene INS-1 in cells with a control vector (pSUPER) or a SiRNA-Sirt1 vector (SiRNA Sirt1).
(B and C) Western blot analyses of targets involved in insulin synthesis and secretion using specific antibodies: cEBP/b, insulin receptor a and b, and
kir6.2, one of the K
þ channel receptor subunits.
(D) Measurement of ATP/ADP levels in INS-1 control cells (open bars) or Sirt1 knockdown cells (black bars) treated with 16.7 mM glucose (þ)o r4m M
glucose ( )( n ¼ 3 experiments done in triplicate, *p , 0.005 in the pSUPER experiment; ANOVA).
(E) Western blot analysis for UCP2 in INS-1 control cells (pSUPER) or knockdown cells (SiRNA Sirt1).
(F) Northern blot analysis for UCP2 in INS-1 control cells (pSUPER) or knockdown cells (SiRNA Sirt1).
(G) NADH levels in INS-1 cells after glucose addition as determined by autofluorescence [46] and expressed as arbitrary units. Cells stably transfected
with control or Sirt1 SiRNA vectors were used (n ¼ 2, *p , 0.05 compared with no glucose).
(H) UCP2 protein levels in isolated pancreatic islets of two wild-type or two Sirt1 KO mice. Tubulin or actin was used as loading control in all Western
and Northern blots.
DOI: 10.1371/journal.pbio.0040031.g004
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Sirt1 Regulates Insulin Secretionbetween the UCP2 and insulin production in b cells (36).
Thus, we determined by Western blot the levels of UCP2 in
control and Sirt1 knockdown cells. Strikingly, there was a
signiﬁcant increase in the UCP2 protein level in the knock-
down cells (Figure 4E). This increase in protein level was
mirrored by an increase in the mRNA in the same cells
(Figure 4F), indicating that Sirt1 regulates UCP2 transcrip-
tion. It was previously shown that UCP2 expression reduced
NADH levels [45]. We therefore determined NADH levels by
autoﬂuorescence [46] and found a signiﬁcantly lower level of
NADH in the knockdown cells (Figure 4G).
Western blot for UCP2 in Sirt1 KO mice showed a similar
effect. We observed an increase in UCP2 protein in the whole
pancreas (unpublished data), which is a measure of the islets,
since UCP2 is expressed in only the endocrine cells of the
pancreas [38]. Moreover, UCP2 protein was also up-regulated
in isolated islets of Sirt1 KO mice (Figure 4H). In summary,
our expression studies suggest that Sirt1 is a repressor of
UCP2 transcription in b cells, and by repressing this UCP, this
sirtuin may allow cells to secrete insulin in response to
glucose.
Sirt1 Binds to the UCP2 Promoter
To study further the repression of UCP2 by Sirt1, we
carried out reporter assays in 293T cells transfected with a
chloramphenicol acetyl-transferase (CAT) gene, whose ex-
pression is driven by the UCP2 promoter. Cells were also
transfected with a control vector or with an expression vector
for PPARc, which is known to bind to and activate the UCP2
promoter [47]. In a control experiment, PPARc activated the
reporter in this assay (Figure 5A, left bars). In a parallel
experiment, cells were also co-transfected with a Sirt1
expression vector. Sirt1 clearly repressed the activation of
the UCP2 promoter (Figure 5A, right bars). Repression of this
reporter by endogenous or expressed Sirt1 was alleviated by
nicotinamide, a known inhibitor of Sirt1 (unpublished data).
To determine whether repression of UCP2 was due to the
direct binding of Sirt1 at the promoter, INS-1 cells were
subjected to chromatin-immunoprecipitation, using Sirt1 or
control antibodies. Primers speciﬁcally designed to span a
known regulatory region of the UCP2 promoter (43) (Figure
5B, primer set 5) were used to probe by PCR the DNA in the
immunoprecipitate. Sirt1 bound to this region of the UCP2
promoter in the control cells (Figure 5C, column 3) and to a
signiﬁcantly lesser extent in the Sirt1 knockdown cells (Figure
5C, column 6). Control primers designed in a different region
of UCP2 upstream DNA (Figure 5B, primer set 4) showed no
ampliﬁcation (Figure 5C, columns 2 and 5). An anti-gal4
antibody control using primer set 5 also showed no binding
(Figure 5C, columns 1 and 4). These ﬁndings indicate that
Sirt1 represses UCP2 transcription by binding directly at the
UCP2 promoter.
Reduction of UCP2 Restores Insulin Secretion in Sirt1
Knockdown b cells
The above ﬁndings show that Sirt1 represses UCP2, and
alleviation of this repression correlated with blunted insulin
secretion in response to glucose. To address whether the
increase in UCP2 in Sirt1 knockdown cells caused the failure
to secrete insulin, UCP2 was also knocked down in INS-1 cells
with reduced Sirt1. Stable cell lines with UCP2 knocked down
by SiRNA were derived from two different lines in which
Sirt1 was already knocked down, as well as from control INS-1
cells. Several different UCP2 sequences were inserted into a
pSUPER hairpin vector with the neomycin-resistance drug
marker. These constructs were transfected into the SiRNA
Sirt1 puromycin resistant cells or control cells, and stable
populations of NeoR cells were assayed for UCP2 RNA and
protein by Northern and Western blots. In the case of two
different UCP2 SiRNA constructs, the levels of UCP2 RNA
(Figure 6A) and protein (unpublished data) were clearly
reduced in transfected cells. The levels of Sirt1 remained low
in the double knockdown cells (unpublished data).
Next, glucose-stimulated insulin secretion was assayed in
Sirt1 or UCP2 knockdown cells and in cells with both Sirt1
and UCP2 knocked down. The Sirt1 knockdown cells were
again defective in induction of insulin secretion, as expected.
However, the double knockdown cells or cells with only the
UCP2 SiRNA construct displayed insulin secretion in
response to glucose (Figure 6B). A similar effect was observed
in the second Sirt1 knockdown line in which UCP2 was also
knocked down (unpublished data). This result demonstrates
that the failure of Sirt1 knockdown cells to secrete insulin is
due to the elevated levels of UCP2 in these cells. We conclude
Figure 5. Sirt1 Binds at the UCP2 Promoter and Represses the Gene
(A) In vitro CAT assay. 293T cells were transfected with a CAT reporter
driven by the UCP2 promoter. Cells were also co-transfected with Sirt1 or
not and with PPARc or not, as indicated. CAT activity was determined (n
¼3 experiments done in triplicate, *p , 0.05 in the no Sirt1 transfection
experiment, ANOVA).
(B) Schematic representation of the primer sets (arrows) in the UCP2
promoter (shown schematically and with excerpted DNA sequence).
(C) Chromatin-immunoprecipitation (IP) was carried out on INS-1 control
cells (lanes 1–3) or Sirt1 knockdown cells (columns 4–6) using Sirt1
antibody or a Gal4 control antibody, as indicated. PCR was carried out
with the indicated primers. INPUT (columns 7–10) refers to PCR carried
out on samples prepared prior to immunoprecipitation. Negative
controls for the PCR (minus DNA) are also indicated (columns 11 and 12).
DOI: 10.1371/journal.pbio.0040031.g005
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Sirt1 Regulates Insulin Secretionthat Sirt1 acts as a positive regulator of insulin secretion in
wild-type cells by repressing UCP2, thereby allowing coupling
of glucose metabolism to ATP synthesis.
UCP2 Levels Increase in Food-Deprived Mice
Does the regulation of UCP2 play any role in the normal
secretion of insulin in b cells of wild-type mice in response to
diet? To address this question, we starved wild-type mice O/N
and compared the levels of UCP2 in whole pancreas and in
islets to mice feeding ad libitum. Importantly, we found an
increase in UCP2 mRNA levels in whole pancreas of starved
mice compared with the fed mice (Figure 7A). Further, the
levels of UCP2 protein were also increased in starved mice
(Figure 7B).
In order to determine whether Sirt1 regulated this
induction of UCP2 in mice, we starved Sirt1 KO mice O/N
and compared the effect of starvation on UCP2 protein levels
to wild-type mice. Four pairs of wild-type and KO littermates
were compared and gave comparable results. The levels of
UCP2 in KO mice fed ad libitum were elevated compared with
wild-type, as expected (Figure 7C). Most importantly, these
elevated levels in the fed KO mice were not further induced
by starvation. In contrast, starvation induced UCP2 in wild-
type mice, as before. A similar pattern of UCP2 RNA
induction by starvation in wild-type but not KO mice was
observed by RT-PCR (Figure 7D). The above ﬁndings suggest
that an increase in UCP2 in b cells is part of a normal
mechanism to regulate the capacity of b cells to produce
insulin. Moreover, this induction appears to be mediated by
alleviation of Sirt1-mediated repression.
These ﬁndings suggest that starvation causes a decrease in
Sirt1 activity in b cells. In yeast, Sir2p activity is regulated by
the NAD/NADH ratio. We thus measured NAD and NADH in
the pancreas of seven fed and seven starved wild-type mice.
Strikingly, there was a signiﬁcant decrease in the level of NAD
but not NADH in the starved mice (Figure 8). The level of
Sirt1 protein in starved pancreas is roughly comparable to
fed controls (unpublished data). These ﬁndings suggest that
changes in NAD levels in the pancreas regulate Sirt1 activity
and insulin secretion in response to diet.
Discussion
In this study we show that Sirt1 regulates insulin secretion
in pancreatic b cells. Both in Sirt1 KO mice and in cultured b
cell lines, a reduction in Sirt1 levels reduces the capacity of
these cells to secrete insulin in response to glucose. Classical
Figure 6. Knockdown of UCP2 in Sirt1 Knockdown Cells Restores Glucose-Induced Insulin Secretion
(A) Northern blot for UCP2 RNA in control INS-1 cells, and cells knocked down for Sirt1 (SiRNA Sirt1), UCP2 (SiRNA UCP2), or both Sirt1 and UCP2 (SiRNA
Sirt1-SiRNA UCP2). RNAs were quantitated by densitometry, setting the level of UCP2 in control cells at 1.0.
(B) Insulin secretion in INS-1 control cells and cells with knockdown levels of Sirt1, UCP2, or both Sirt1 and UCP2 after treatment with 16.7 mM glucose
(þ) or 4mM glucose ( ) for 1 h (n ¼ 3 experiments done in triplicate, *p , 0.05 in SiRNA Sirt1-SiRNA UCP2, ANOVA).
DOI: 10.1371/journal.pbio.0040031.g006
Figure 7. UCP2 mRNA or Protein Levels in Fed or Starved Wild-Type Mice
(A) Northern blot for UCP2 in whole pancreas of two ad libitum mice and
two mice starved for 18 h.
(B) Western blot for UCP2 in isolated islets in two ad libitum and two
starved mice.
(C) Western blot for UCP2 in wild-type (WT) or Sirt1 KO littermates either
fed ad libitum or starved for 18 h. The experiment shown is
representative of four pairs of wild-type and KO littermates analyzed.
(D) RT-PCR for UCP2 in wild-type or Sirt1 KO mice fed or starved.
DOI: 10.1371/journal.pbio.0040031.g007
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Sirt1 Regulates Insulin Secretionstudies show that an increase in the ATP/ADP ratio due to
glucose metabolism is the critical trigger in the induction of
insulin secretion. In cells with reduced Sirt1, the increase in
this ratio is blunted due to elevated levels of UCP2, which
reduces the synthesis of ATP during respiration. Sirt1 directly
represses UCP2 by binding to the promoter. Thus, by
controlling UCP2, Sirt1 regulates the amplitude of insulin
induction by glucose. We do not know whether the low levels
of insulin in the whole body of Sirt1 KO mice represents a b
cell defect, an indirect consequence of the elevated glucose
tolerance in these animals, or both.
The use of UCP2 to regulate insulin production is distinct
from the canonical role of UCPs. By uncoupling respiration
from ATP synthesis in brown fat, for example, UCP1
generates heat and is critical for the non-shivering thermo-
genesis in rodents (reviewed in [48]). Here UCP2 is used to
modulate the levels of ATP made in b cells, which dictates the
extent of insulin secretion. Our ﬁndings are consistent with
the elevated basal levels of insulin observed in fasted UCP2
KO mice [36] and suggest that Sirt1 and UCP2 are
physiologically relevant regulators of insulin production
(see ‘‘UCPs and Longevity–Cellular Basis’’).
Physiology of Insulin Regulation by Sirt1
The fact that Sirt1 represses UCP2 expression in b cells is
intriguing in light of the role of this sirtuin as a regulator of
CR in lower organisms. Our ﬁndings indicate that Sirt1 may
link the amplitude of insulin secretion to the diet. We found
that O/N starvation led to an increase in the levels of UCP2
protein and RNA in the pancreas and isolated islets. This
increase did not occur in Sirt1 KO mice, which already
displayed higher levels of UCP2 when fed ad libitum. These
ﬁndings suggest that regulation of UCP2 by Sirt1 is a
physiologically important mechanism to blunt the chronic
levels of insulin in starved animals. This mechanism may
explain why insulin levels are so low during fasting, even
though b cells are actively metabolizing fat and respiring (see
following section). It remains to be seen whether this
mechanism is important during long-term CR.
Regulation of Pancreatic Sirt1 Activity by NAD/NADH and
Diet
The action of mammalian Sirt1 appears to differ from that
of lower organisms. In C. elegans, sir2.1 appears to repress the
output of the insulin/IGF pathway [9], but the mechanism has
not been described. Also, Sir2 activity is activated during CR
to extend the life span in yeast and Drosophila [11,49].
However, in mammals Sirt1 functions as a positive regulator
of insulin secretion, raising the possibility that its activity in b
cells is actually reduced by O/N starvation..
A lowering of Sirt1 activity occurs concomitant with the
shift from carbohydrate-based metabolism to utilization of
fatty acids, which is known to follow food deprivation.
Because fatty acids are more reduced than carbohydrates,
their metabolism to CO2 converts more NAD to NADH.
Indeed, we show that the NAD/NADH ratio falls in pancreas
of starved mice compared with fed controls, although we
cannot be certain this change occurs speciﬁcally in islets,
which represent a small percentage of pancreatic mass. A
decrease in the NAD/NADH ratio has also been shown to
down-regulate Sir2 activity in other physiological contexts
[15,21,50].
UCPs and Longevity–Cellular Basis
The question arises whether the up-regulation of UCPs we
ﬁnd in b cells occurs in other tissues during food limitation or
long-term CR. In a horizontal study of mice, a good
correlation was found between the life span and the level of
uncoupling of respiration [51]. It has also been shown that
overexpression of a UCP increased the life span in Droso-
phila [52]. UCPs may confer beneﬁt by damping production
of reactive oxygen species during respiration. In one
example, mitochondria from UCP3 KO mice generated
higher levels of superoxide [53,54], suggesting that some
degree of uncoupling can be beneﬁcial by controlling reactive
oxygen species production [55].
There are several reports that levels of UCPs may increase
as a consequence of CR [56,57], but these ﬁndings are still not
conclusive [58]. It will be interesting to see whether Sirt1
regulates UCPs in tissues other than b cells, and whether
there is a broader change in the expression of UCPs during
acute food limitation or CR.
Summary and Perspective
The induction of insulin secretion by glucose in pancreatic
b cells has been a paradigm in mammalian cellular
physiology. Here we describe a new level of regulation in
which Sirt1 represses UCP2 to modulate the amplitude of
insulin induction by glucose in b cells. We suggest that this
mechanism serves to regulate chronic levels of insulin in
accord with levels of food intake. This mechanism may
reinforce the low levels of insulin production during food
limitation and coordinate insulin release from b cells to the
insulin sensitivity of metabolic tissues set by the diet.
Regulation of UCP2 by Sirt1 may also be an important axis
that is dysregulated by excess fat to contribute to obesity-
induced diabetes.
Figure 8. NAD and NADH Levels in Fed and Starved Mice
Measurements were made in pancreases of seven fed and seven starved wild-type mice, and levels are expressed as nmol per gram of tissue. The
decrease in NAD in starved mice is significant with p , 0.0005, while the NADH levels in fed versus starved are not significantly different.
DOI: 10.1371/journal.pbio.0040031.g008
PLoS Biology | www.plosbiology.org February 2006 | Volume 4 | Issue 2 | e31 0217
Sirt1 Regulates Insulin SecretionMaterials and Methods
Cell culture. INS-1 (a gift from K. Olson, Michigan State University,
Lansing, Michigan, United States) and MIN6 cells (a gift from S. Imai,
Washington University in St. Louis, St. Louis, Missouri, United States)
were grown at 5% CO2/95% air at 37 8C. INS-1 cells were cultured in
RPMI-1640 medium containing 11.1 mM glucose supplemented with
10% fetal bovine serum (FBS), 1 mM pyruvate, 10 mM HEPES, 50 lM
2-mercaptoethanol, 100 U penicillin/ml, and 100 lg/ml streptomycin.
Cells were passaged weekly after trypsin-EDTA treatment. All studies
were performed in INS-1 passages between 70 and 84. MIN6 cells
were grown in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
containing 4.5 g/l glucose and L-glutamine, 15% FBS, 3.4 g/l sodium
bicarbonate, 5 ll/l 2-mercaptoethanol, 100 U penicillin/ml, and 100
lg/ml streptomycin. All studies were performed between passages 27
and 35.
Animal experimentation. The Sirt1 KO animals and their controls
were obtained from M. McBurney [39]. The mice were housed under
controlled conditions: temperature (25 6 1 8C) and light cycle (7 A.M.–
7 P.M.). Animals were fed with regular chow and cared for in
accordance with the MIT Committee on Animal Care (Massachusetts
Institute of Technology, Cambridge, Massachusetts, United States).
Assays were performed on 4- to 8-mo-old males (129/Sv CD1 mixed
background).
Retroviral infection of INS-1 and MIN6 cells. Phoenix cells were
transfected with either pBABE, pBABE-T1 [18], pSUPERretro
(Oligogene), pSUPERretro-SiRNA-T1 (59-GCTGCATCCAAGGGC
CATG-39), or pSUPER retro SiRNA-GFP (gift from T. Brummelkamp,
Whitehead Institute for Biomedical Research, Cambridge, United
States of America) using Lipofectamine 2000 (Invitrogen, Carlsbad,
California, United States). 48 h post-transfection, the medium
containing retroviruses was collected and added with 1 mg/ml
polybrene to INS-1 or MIN6 cells. Infected cells were treated with 1
mg/ml of puromycin for selection.
In order to create double knockdown cell lines, INS-1 cells stably
transfected with control vector and pSUPERretro-SiRNA-T1 were
infected with retroviruses carrying pSUPER retro-SiRNA UCP2.
These cells were selected with 200 lg/ml gentamicin (Mediatech,
Herndon, Virginia, United States).
Cell-growth analysis. INS-1 cells were seeded at 1 3 10
5 cells/6 cm
plate. Cells were collected, resuspended in the same volume of
medium, and counted using the trypan blue exclusion method.
Insulin secretion assay. 0.53106 cells were placed in 12-well plates
in growing medium. In the case of INS-1 cells, fresh medium
containing 4.0 mM glucose was added after 2 d. Cells were cultured
for an additional day. In all cases, the medium was removed on the
day of the experiment, and the cells washed three times with warm
KRB buffer (119 mM NaCl, 4.74 mM KCl, 2.54 mM CaCl2, 1.19 mM
MgS04, 1.19 mM KH2P04, 25 mM NaHC03, 10 mM HEPES [pH 7.4], 0.1
g BSA). The cells were then incubated with 1 ml of KRB at 37 8C for
60 min. At the end of the incubation, cells were washed with KRB
medium. The cells were then incubated with KRB containing
different glucose concentrations (4–16.7 mM for INS-1 and 4–20
mM for MIN6) for 1 h at 37 8C. The supernatant was collected and
insulin was measured by ELISA using mouse insulin as a standard
(Alpco Diagnostics, Windham, New Hampshire, United States). Cells
were then incubated O/N with acidiﬁed EtOH (75% EtOH, 1.5%
HCl). Protein determination was performed using the Bio-Rad Dc
Protein assay (Hercules, California, United States). The amounts of
secreted insulin were corrected by the amounts of cell protein in each
well.
Immunoﬂuorescence. Pancreas was isolated from wild-type or
Sirt1 KO mice and ﬁxed in 4% paraformaldehyde. Consecutive 8-lm
sections were immunostained with anti-Sirt1 antibody at 1:100
dilution (Upstate-Chemicon, Charlottesville, Virginia, United States).
DAPI was used to stain the nuclei. Hematoxylin and eosin was used to
visualize islets.
In vivo insulin measurement. Mice were subjected to O/N fast
followed by intraperitoneal glucose injection (1 g/kg body weight).
Blood samples were collected from the tail vein the night before the
experiment (ad libitum), right before the glucose injection (time 0),
and after the different time points indicated in Figure 2E. Insulin
levels were measured using the Ultrasensitive Mouse Insulin EIA
(Alpco Diagnostics) according to manufacturer’s speciﬁcations.
Glucose tolerance test. Mice were fasted O/N (16 h) and injected
intraperitoneally with a saline glucose solution at 1g/kg body weight.
Plasma glucose levels were measured from tail blood before and 2, 5,
10, 25, 40, 80, and 120 min after the glucose injection. The test was
repeated ﬁve times with results comparable to those in Figure 2D.
Western blot analysis. Cells were lysed in RIPA buffer (1%
TritonX-100, 158 mM NaCl, 5 mM EDTA, 10 mM Tris [pH 7.0],
protease inhibitors [Boehringer, Mannheim, Germany], 1 mM DTT,
and 0.1% phenylmethylsulfonyl ﬂuoride), sonicated, and centrifuged
at 14,000 rpm for 10 min. Proteins were separated by SDS-PAGE,
transferred to nitrocellulose membrane (Schleicher and Schuell
Bioscience, Dassel, Germany), and were probed with a polyclonal
antibody against Sirt1 or monoclonal anti-actin antibody (Chemicon,
Temecula, California, United States). The UCP2 antibody (Calbio-
chem, San Diego, California, United States) was used in 1:1000
dilution. The cEBP/b, the insulin receptor alpha and beta, and the
kir6.2 antibodies (Santa Cruz Biotechnology, Santa Cruz, California,
United States) were used at 1:200, 1:200, 1:500, and 1:200, respectively.
Chromatin immunoprecipitation. Assays were performed on cells
as previously described according to the Farnham protocol (http://
mcardle.oncology.wisc.edu). Immunoprecipitations were performed
with 1lg of Sirt1 antibody. PCR primers were designed to span a
regulatory region in the UCP2 promoter (59-
CGTCTGTTCAAAGCGTCTCA; 59-CCAGCTGGAGTCTTCTCCTT)
(set 5) or a control region in the UCP2 promoter (59-
AGGTTGTTTCTGGGCCATGTGCTCTAA; 59-T A G A C C C T G G C
CACCCTGAGCGCGAAAT) (set 4).
Islets isolation and morphometric analysis. Islets were isolated
using a collagenase technique as described previously [59]. The
pancreas was dissected and islets separated by incubation with
collagenase at 37 8C. Islets were then hand-picked using a microscope.
Islets were used for Western blot analyses or for glucose-induced
insulin secretion assays. To measure insulin secretion, islets were
incubated in KRB with 4 mM glucose for 1 h and then incubated with
KRB containing different glucose concentrations (4–20 mM) for 1 h
at 37 8C. The experiment was carried out twice with four mice per
treatment, and the repeat experiment gave data comparable to Fig-
ure 2E.
Four to ﬁve pancreases each from WT, Sir2þ/ , and Sir2 /  mice
were ﬁxed in 2% chilled paraformaldehyde, and parafﬁn embedded,
and three sections (5 lm) separated by at least 100 lm were dewaxed
using xylene, rehydrated through serial dilutions of ethyl-alcohol, and
subjected to antigen retrieval using 10 mM citrate (pH 6.1), followed
by DAKO high pH antigen retrieval solution (Dako, Glostrup,
Denmark). The sections were washed and stained with the respective
antibodies in staining buffer with 100 mM NaCl, 3% BSA, 0.5%
Triton-X-100, and 50 mM Na-PO4 (pH 7.4). Primary antibodies
included sheep anti-insulin (The Binding Site, Birmingham, United
Kingdom), mouse anti-glucagon (Sigma, St. Louis, Missouri, United
States), and rabbit anti-somatostatin (Dako). The entire pancreatic
section of each stained slide was arbitrarily divided into non-
overlapping contiguous portions (using a microscope inset measuring
guide) and imaged at 103 magniﬁcation. The islet area (in square
micrometers) and the total area of each section were determined by
tracing the outline to assess the area of the islets, using image
analyzer software (Image-Pro 4.1 Plus). The percentage of islet cell
area in the pancreas was expressed as a percentage of the total
pancreatic area. For 43images, islets were stained using a cocktail of
antibodies against insulin, glucagon, and somatostatin and HRP-
linked secondary antibodies with DAB as a chromogen.
ATP/ADP measurements. 1 3 10
6 cells were washed with 13 PBS.
Ice-cold 6% (v/v) HClO4 was added, and immediately the cells were
scraped from the plate. The solution was neutralized with 1 M
KHCO3, centrifuged brieﬂy, and the supernatant was passed through
a 0.2-m ﬁlter (Nanosep, Lund, Sweden), and subjected to reversed
phase chromatography using a Targa C18 250 3 4.6 mm 5-mm
column as described in [61]. Nucleotides were detected at 260 nm
with a Waters 486 tunable detector. Peak heights were measured.
Nucleotide identities were conﬁrmed by co-migration with known
standards.
RNA analyses. Northern blot—Total RNA from INS-1 cells was
extracted using Triazol reagent (Invitrogen). For Northern blot
analysis, 10 lg of RNA samples was separated on a formaldehyde gel,
transferred to nylon membrane, and then hybridized with gene-
speciﬁc probes. Normalization of mRNA was done by using actin as
probe (kind gift from K. Olson). For whole-pancreas RNA extraction,
fresh pancreas was stored in the RNA later solution (Ambion, Austin,
Texas, United States) before extracting total RNA with the Qiagen
system (Qiagen, Valencia, California, United States). The UCP2 probe
was a kind gift from D. Ricquier, CNRS, Paris, France. RT-PCR/cDNA
was synthesized from 1 lg of total RNA from the pancreas. The
reverse transcriptase reaction was performed at 25 8C for 10 min, 42
8C for 1 h, 95 8C for 5 min, for one cycle. The PCR reaction (95 8C for
30 s, 58 8C for 30 s, 72 8C for 30 s, for 25 cycles) was performed using
the respective sense and antisense oligonucleotide primers: UCP2: 59-
GCCCGGGCTGGTGGTGGTC and 59-CCCCGAAGGCAGAAG
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and 59-ACCGCTCGTTGCCAATAGTGATG.
CAT assay. Transfections for CAT assays were done as described
[60]. 293T cells were transiently transfected with pSU2N2-mUCP2-
CAT (which contains 7 kb of the mouse UCP2 promoter; gift from D.
Ricquier), pCMV-betaGal (to correct for transfection efﬁciency), and
either pCMV-mSirt1 and pSPORT6-mPPAR-gamma2 (gift from B.
Spiegelman, Harvard Medical School, Massachusetts, United States of
America) or their respective empty vectors. 24 h later, total CAT
enzyme levels were measured by ELISA (Roche, Basel, Switzerland).
NAD and NADH determination. NAD and NADH nucleotides were
measured as described [15]. About 10 mg of frozen pancreas tissues
was homogenized in 300 ll of acid extraction buffer to obtain NAD
concentration, or alkali buffer to obtain NADH concentration. 240 ll
of supernatant was neutralized with 120 ll of buffer. The concen-
tration of nucleotides was measured ﬂuorimetrically after an
enzymatic cycling reaction using 2 ll of sample. All values were
detected within the linear range and are expressed as nmol per gram
of tissue.
Quantitation of NADH autoﬂuorescence and glucose uptake. 1.53
106 INS-1 cells were seeded in six-well plates. Fresh medium
containing 4.0 mM glucose was added the day before the experiment.
The medium was removed on the day of the experiment, and the cells
washed 33with warm KRB buffer. The cells were then incubated with
1 ml of KRB at 37 8C for 1 h. At the end of the incubation, the media
was removed and the cells were incubated for 10 min with KRB
containing different glucose concentrations: 4–16.7 mM (for NADH
determination), or 200 lM 2-NBDG (Molecular Probes) for glucose
uptake determination. At the end of the incubation, cells were
washed 33with cold 13PBS. We then used a four-laser LSR II digital
ﬂow cytometer (Becton-Dickinson, Mountain View, California,
United States) with Diva software. The 488-mm laser excited the
ﬂuorescent glucose, and emission was detected with a 530/30BP ﬁlter
and expressed as arbitrary units. NADH was measured according to
Thorell [46] with a 355-mm laser and detected with a 440/40BP ﬁlter.
Cell viability was assessed using PI. Data were analyzed with FlowJo
(Tree Star, Ashland, Oregon, United States).
Supporting Information
Figure S1. Growth Curve Plot of Cell Number vs. Time of INS-1 Cells
Transfected with pSUPER (black line) or SiRNA Sirt1 (red line)
Found at DOI: 10.1371/journal.pbio.0040031.sg001 (163 KB TIF).
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